The work of the Division of Oncology bridges the worlds of basic science, clinical diagnosis and the treatment of cancer. Our basic investigative activities concentrate on immunology, genetics/genomics, pharmacology, DNA repair and oncogene action. Our clinical science covers each cancer type; has a strong focus in clinical trials of new diagnostic and therapeutic approaches, and in correlative laboratory studies. Our work is supported by a portfolio of peer-reviewed grants, industrial agreements and research endowments.
Normal cells in the body follow an orderly path of growth, division, and death. Programmed cell death is called apoptosis, and when this process breaks down, cancer begins to form. Unlike regular cells, cancer cells do not experience programmatic death and instead continue to grow and divide. This leads to a mass of abnormal cells that grows out of control.
Treatment Plans will depend on the physician's expert opinion based on the diagnosed tumour or metastasis (Tumour Types). There is no one-size-fits-all treatment for cancer. Treatment options include chemotherapy, surgery, radiation therapy and more, and in some cases a patient will require a combination to maximise the effectiveness of treatment.
Q. Is exercise recommended during treatment?
A. Yes, exercise has been shown to be safe for people going through active cancer treatments, and in fact can be one of the best ways to relieve some of the symptoms associated with your cancer or cancer treatment.